Immediate effects of 850 nm Diode Laser on patients with Cervical Myofascial Pain Syndrome: a Randomized-controlled trial - Trial PACTR202306638021904
Access comprehensive clinical trial information for PACTR202306638021904 through Pure Global AI's free database. This Phase 4 trial is sponsored by Ahmed Ali Zahreldin and is currently Completed. The study focuses on Musculoskeletal Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ahmed Ali Zahreldin
Ahmed Ali
Timeline & Enrollment
Phase 4
Aug 01, 2021
Jan 01, 1900
Summary
Background: Myofascial pain syndrome (MPS) is one of the most common causes of chronic neck pain that associated with specific trigger points. Low level laser therapy (LLLT) is a physical therapy modality and a light-based procedure that is used to reduce inflammation and edema; treat pain and neurological disorders; and to promote healing of wounds and deeper tissues of patients with MPS. Therefore, the aim of this randomized controlled trial was to assess and evaluate the immediate effects of LLLT added to the conventional physical therapy in comparison with the conventional physical therapy alone on pain intensity, pressure pain threshold (PPT) and cervical range of motion (ROM) in cervical MPS patients.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202306638021904
Non-Device Trial